JUL 24, 2021 8:28 AM PDT

Causal Link Between Cannabis Use Disorder and Schizophrenia

WRITTEN BY: Annie Lennon

A study from Denmark has found that the proportion of schizophrenia cases linked to cannabis use disorder has increased by 3-4 times in the last two decades. The findings were published in JAMA Psychiatry

Previous research has found that people who use cannabis are at an increased risk of developing schizophrenia. However, most studies have suggested that cannabis may interact with other risk factors to cause the condition. 

For the present study, the researchers examined data from 7,186,834 individuals from Danish national health registry data. All individuals were aged 16 years or older at some point between 1972 and 2016. They included equal numbers of men and women. 

From analyzing the data, the researchers found that while 2% of schizophrenia cases in the country were linked to cannabis use disorder in 1995, the same figure increased to 4% in 2000, and to 8% in 2010. 

The researchers say that these increases were expected given increases in the use and potency of cannabis over time. They add that the findings point towards a causal link between cannabis and the development of schizophrenia. 

The study goes against previous theories stating that rates of schizophrenia remain constant over time and are independent of geographical location. This argument has previously been used to argue against a possible causal link between cannabis and schizophrenia. 

"Of course, our findings will have to be replicated elsewhere before firm conclusions can be drawn," said Carsten Hjorthøj, one of the authors behind the study. 

"But I do feel fairly confident that we will see similar patterns in places where problematic use of cannabis has increased, or where the potency of cannabis has increased, since many studies suggest that high-potency cannabis is probably the driver of the association with schizophrenia," he added. 

The findings are "particularly important with the increasing legalization of cannabis for both medicinal and recreational uses seeming to lead to an increase in the perception of cannabis as relatively harmless and possibly in the uptake of cannabis use, especially among youth," wrote the researchers. 

 

Sources: JAMA PsychiatryThe LancetMedscapeCNN

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 22, 2021
Cannabis Sciences
Cannabis Use Disorder in Pregnancy Linked to Infant Health Problems
APR 22, 2021
Cannabis Use Disorder in Pregnancy Linked to Infant Health Problems
Researchers have found that babies born to mothers diagnosed with cannabis use disorders at delivery are more likely to ...
APR 22, 2021
Cannabis Sciences
Home Genetic Tests That Can Tailor the Best Cannabis Strains for You
APR 22, 2021
Home Genetic Tests That Can Tailor the Best Cannabis Strains for You
Our endocannabinoid system (ECS) is claimed to be as individual as our fingerprint or iris, with different cannabis ingr ...
APR 27, 2021
Cannabis Sciences
CBD Doesn't Reduce Pain, but Makes it Less Unpleasant
APR 27, 2021
CBD Doesn't Reduce Pain, but Makes it Less Unpleasant
While anecdotal reports tout cannabidiol’s (CBD) utility for pain relief, up until now, there’s been limited ...
JUN 10, 2021
Health & Medicine
Medical Cannabis Use Correlates with Reduced Cigarette Use
JUN 10, 2021
Medical Cannabis Use Correlates with Reduced Cigarette Use
  Here’s a bonus effect of using medical cannabis — you’re more likely to give up smoking accordi ...
JUN 26, 2021
Cannabis Sciences
CBD Shows Promise for Lowering Blood Sugar
JUN 26, 2021
CBD Shows Promise for Lowering Blood Sugar
Whether or not cannabis can help manage symptoms of diabetes is unclear. While some studies support cannabis as a potent ...
AUG 04, 2021
Health & Medicine
Cannabis Drug Sativex to Be Tested in Phase II Brain Tumor Trial
AUG 04, 2021
Cannabis Drug Sativex to Be Tested in Phase II Brain Tumor Trial
  A phase II trial is being planned to test the cannabis-derived drug Sativex, in patients with aggressive brain tu ...
Loading Comments...